Esbriet

pirfenidone · H.A.C. Pharma
AUTHORISED IN THE EU

What Esbriet is used for

Esbriet is indicated in adults for the treatment of idiopathic pulmonary fibrosis.

Approved use, as published by the European Medicines Agency.

Key facts

Brand
Esbriet
Active substance
pirfenidone
Disease area
Idiopathic Pulmonary Fibrosis; Lung Diseases; Respiratory Tract Diseases
Medicine group
Immunosuppressants
ATC code
L04AX05
Marketing authorisation holder
H.A.C. Pharma
Authorised in the EU since
2011

Official information

In India

Specialist medicine: started and supervised by a specialist doctor or hospital. This page is a plain-language summary of public official information, not medical advice; follow your doctor and the official product information.

Common questions

What is Esbriet used for?

Esbriet is indicated in adults for the treatment of idiopathic pulmonary fibrosis.

What is the active substance in Esbriet?

Esbriet contains pirfenidone.

Who makes Esbriet?

The EU marketing authorisation holder is H.A.C. Pharma.

Source: European Medicines Agency medicines data (ema.europa.eu), reproduced with acknowledgement of the source. Page made 5 November 2026 by Satya Babu.

← All specialty medicines, EU

For information only, not medical advice. This page is a plain-language summary written from standard prescribing information and the public guides linked below. Brands sometimes change their formula, so always check the composition printed on the pack. Doses here are typical adult doses; yours may differ. Do not start, stop or change a medicine without your doctor or pharmacist, and keep all medicines away from children. In an emergency, call 112 (India) or your local emergency number.